Dr. Carmen Guguta, Technobis Crystallization Systems, describes the time-consuming challenges of current crystallisation process, and how innovative analytical instruments are reducing the time it takes to develop drugs to market-ready status.
Josh Needle, managing director - Life Sciences at Cielo, shares his perspective on the key talent acquisition (TA) trends impacting the pharmaceutical industry in 2023 and guidance for TA leaders on how to stay ahead of them.
2023 will bring new regulatory changes linked to process digitalisation and automation, REPHINE’s Dr. Eduard Cayón discusses the implications for quality control and how pharma companies can stay ahead of the curve.
In this 2023 prediction piece, Lisa Owens and Jerry Temko, Major, Lindsey & Africa, argue that the life sciences hiring landscape looks set to be busy as companies look to recent big tech redundancies to source data-savvy legal talent.
Kay Scheffler, product manager - applied microscopy at Leica Microsystems, explains how microscopy is key in identifying particle contamination and ensuring quality control in the pharma industry.
Berry Global Healthcare is introducing a comprehensive bundle solution to help customers capitalise on the increasing demand for child-resistant (CRC) and tamper-evident (TE) packaging for the pharma and herbal market for syrup and liquid medicines.
Rebekah Jordan spoke with Katrin Pauls (Lonza), Mark Hilhorst (Jekson Vision), and Christoph Jansen (Mettler Toledo), to discuss the factors and challenges involved in the pharma industry's move towards sustainable, future-proofed QC lab testing.
EPM's Q&A with Jack Dix, head of healthcare strategy and consulting at Kainos, examines technology in genomics research and how cloud data transformation can help to build better patient outcomes.
Paul Smaltz, vice president, pharmaceuticals, at Roquette, explores how taking a more ‘human’ look at the issue of drug shortages and supply chain resilience could help the industry find the fresh ideas it needs to tackle this pressing problem.
A recent panel debate moderated by Christian K. Schneider, head of Biopharma Excellence, explored emerging approaches to clinical research and data collection for therapies linked to rare diseases.
The ideas behind the pharma sector date back to the apothecaries of the middle ages. A naturally progressive industry, pharma has drawn together some great thinkers and speakers
